At the pathological mechanism level, animal model experiments have verified direct nephrotoxic effects of metabolites, with relatively substantial evidence in this domain (102, 112)
In January 2026, Roche announced Phase II results showing 22.5% placebo-adjusted weight loss at 48 weeks, with no plateau in sight
GLP-1 medications may be appropriate for some individuals under the guidance of a healthcare provider, while healthy nutrition and lifestyle habits benefit nearly everyone and remain the foundation of long-term metabolic health
Recommendations for athletes on GLP-1s Still, experts in the field believe there is enough concern not just to warrant further research but to advise athletes to take steps to avoid this loss in lean body mass as much as possible
Body Pharm BPC-157 + TB-500 Pen: Product Specification The Body Pharm BPC-157 + TB-500 pen is a pre-mixed, sealed research injection device containing both peptides co-dissolved at a fixed ratio, supplied with a batch-specific Certificate of Analysis and shipped under refrigerated conditions for UK research use only
Wondr Health, Jan